Thabor Therapeutics (private company)
See something wrong or missing? Let us know
Offices:Paris
Industry:BiotechHealth services
Business model:B2B
Thabor Therapeutics is a company developing an innovative treatment for patients living with chronic mucosal inflammatory diseases
Investors:
we tracked 1 investor
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 2.09M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Thabor Therapeutics
Name | Criteria | |
---|---|---|
![]() |
AbolerIS Pharma
47%
|
|
![]() |
APIM Therapeutics
47%
|
|
![]() |
AptaTargets
47%
|
|
![]() |
Athera
47%
|
|
![]() |
AttgeNO
47%
|
|
![]() |
Cebiotex
47%
|
|
![]() |
Oui
47%
|
|
![]() |
Connecta Therapeutics
47%
|
|
![]() |
Cornea Project
47%
|
|
![]() |
DelSiTech
47%
|
|